Tatva Chintan Pharma Chem trades jubilantly on reporting 9-fold jump in Q2 consolidated net profit
Follow us Now on Telegram ! Get daily 10 - 12 important updates on Business, Finance and Investment. Join our Telegram Channel
Tatva Chintan Pharma Chem is currently trading at Rs. 2316.40, up by 184.35 points or 8.65% from its previous closing of Rs. 2132.05 on the BSE.
The scrip opened at Rs. 2415.30 and has touched a high and low of Rs. 2488.90 and Rs. 2283.25 respectively. So far 17653 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 2,488.90 on 25-Oct-2021 and a 52 week low of Rs. 2000.75 on 11-Aug-2021.
Last one week high and low of the scrip stood at Rs. 2,488.90 and Rs. 2060.80 respectively. The current market cap of the company is Rs. 4725.70 crore.
The promoters holding in the company stood at 79.17%, while Institutions and Non-Institutions held 10.89% and 9.94% respectively.
Tatva Chintan Pharma Chem has reported over 10-fold jump in its net profit at Rs 30.72 crore for the quarter ended September 31, 2021 as compared to Rs 2.92 crore for the same quarter in the previous year. Total income of the company increased by 98.17% at Rs 119.28 crore for Q2FY22 as compared Rs 60.19 crore for the corresponding quarter previous year.
On the consolidated basis, the company has reported 9-fold jump in its net profit attributed to the owners at Rs 32.41 crore for the quarter ended September 31, 2021 as compared to Rs 3.56 crore for the same quarter in the previous year. Total income of the company increased by 2-fold at Rs 126.42 crore for Q2FY22 as compared Rs 61.99 crore for the corresponding quarter previous year.
